Your session is about to expire
← Back to Search
Study Summary
This trial will test the safety of NTS-104 TRIS, given as a single intravenous dose, to healthy subjects at different doses.
- Stroke
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has the NTS-104 TRIS formulation been given clearance by the FDA?
"The consensus amongst our Power team is that NTS-104 TRIS safety rating should be a 1, due to the limited clinical evidence in Phase 1 trials for both efficacy and safety."
Am I eligible to take part in this research endeavor?
"This clinical trial is admitting 32 participants who have suffered a cerebrovascular accident and are between the ages 18 to 65. To be considered, volunteers must consent in writing, possess good health as determined by physical and neurological examinations, present with normal blood pressure/heart rate levels (systolic 90-140mmHg; diastolic 50-90 mmHg; heart rate 45-100 beats per minute), carry out an approved form of birth control if applicable (abstinence, tubal ligation/occlusion , oral contraceptives etc.), report negative pregnancy test results for females at screening and admission."
What objectives is this clinical trial seeking to fulfill?
"The primary outcome measure that Parexel, the study sponsor, has reported is a Change in QTcF Determined by Electrocardiogram over an 8-day period. As for secondary outcomes of this research project, Cmax (the Maximum plasma concentration computed using non-compartmental analysis), Elimination rate constant (λz) (Rate of elimination of IP via non-compartmental analysis based concentrations in plasma), and AUC(inf) (Area under the curve to infinity derived from non-compartmental analysis) will be observed."
Does this research endeavor currently have any openings for participants?
"According to the information available on clinicaltrials.gov, this particular research endeavour is not currently open for enrolment. The trial was first featured on October 21st of 2022 and last modified on September 16th of that same year. Although it has closed its doors at present, there are 342 other studies actively recruiting participants across the United States right now."
Is an age limit set on participation in this trial, and if so, up to what years of life?
"This experiment has identified 18 years old and above, as well as 65 years old and below, to be the eligible age range for potential participants."
Share this study with friends
Copy Link
Messenger